U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
EVOLOCUMAB
LKC0U3A8NJ
US Approved Rx (2015)
First approved in 2015
General
Names
11
Classification
3
Identifiers
20
Subunits
4
Related Substances
1
EVOLOCUMAB
LKC0U3A8NJ
US Approved Rx (2015)
First approved in 2015
General
Approval Year
2015
472
Names
11
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
EVOLOCUMAB (GENETICAL RECOMBINATION)
Preferred Name
English
EVOLOCUMAB
Official Name
English
EVOLOCUMAB [JAN]
Common Name
English
REPATHA
Brand Name
English
EVOLOCUMAB [PURPLE BOOK CDER]
Common Name
English
Showing 1 to 5 of 11 entries
Previous
1
2
3
Next
Classification
3
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Established Pharmacologic Class
Established Pharmacologic Class
[EPC]
PCSK9 Inhibitor
[EPC]
NDF-RT
N0000191731
Designated/Approved
ORPHAN DRUG
Designated/Approved
Treatment of homozygous familial hypercholesterolemia
FDA ORPHAN DRUG
404113
LIPID MODIFYING AGENTS, PLAIN
ATC
CARDIOVASCULAR SYSTEM
LIPID MODIFYING AGENTS
LIPID MODIFYING AGENTS, PLAIN
Other lipid modifying agents
WHO-ATC
C10AX13
Showing 1 to 3 of 3 entries
Previous
1
Next
Identifiers
20
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
DRUG BANK
DB09303
PRIMARY
EVMPD
SUB128552
PRIMARY
USAN
AB-13
PRIMARY
CAS
1256937-27-5
PRIMARY
HSDB
8307
PRIMARY
Showing 1 to 5 of 20 entries
Previous
1
2
3
4
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
LKC0U3A8NJ
EVOLOCUMAB
